Skip to main content

International Vaccine Technology Workshop: Day 2 Agenda

September 18, 2010 - Hyderabad, India
Agenda: DAY 1 | DAY 2

September 18, 2010 – Morning Session – 8:00am-12:30pm
Evaluating Vaccine Technology Options for Developing Countries (continued)

  1. Building Manufacturing Capacity for Influenza Vaccines – 8:00am-9:10am
    Confirmed Moderator: Norbert Hehme, IFPMA
    • Overview of designs and approaches for influenza vaccines (killed virus, live attenuated, recombinant subunit, viral vector, VLP) (20 min)
      • Confirmed Speaker: Dr. Suryaprakash Sambhara, CDC
    • Factors in choosing egg or cell-based technology (20 min)
      • Confirmed Speaker: Simone Blayer, IFPMA Influenza Vaccine Supply
    • Presentations on specific influenza vaccine technologies (30 min)
      • Confirmed Speaker: Dr. Jonathan Liu, MedImmune
      • Confirmed Speaker: Rahul Singhvi, Novavax
  2. Building Vaccine Manufacturing Capacity for Emerging and Other Infectious Diseases – 9:10am-10:25am
    Confirmed Moderator: Dr. Akira Homma, FioCruz
    • Overview of vaccine manufacturing capacity needs for developing countries as determined by public health needs and disease burden (20 min)
      • Confirmed Speaker: Dr. Maria de los Angeles Cortes-Castillo, Pan-American Health Organization
    • Application of novel technologies to improve access to vaccines in developing countries (20 min)
      • Confirmed Speaker: Dr. Doug Holtzman, Gates Foundation
    • Possibilities for flexible manufacturing capabilities for multi-product use (20 min)
      • Confirmed Speaker: Dr. Kim Nelson, CRB Engineering Firm
    • Presentations on specific other vaccines (15 min)
      • Confirmed Speaker: Dr. G.S. Reddy, Indian Immunologicals

 

COFFEE BREAK – 10:25am-11:00am

 

  1. Case Studies on Vaccine Technology Transfer to Developing Countries – 11:00am-12:30pm
    Confirmed Moderator: Dr. John Boslego, PATH
    • Overview of models for technology transfer (private-sector-driven vs. developing country or donor-driven) (10 min)
      • Confirmed Speaker: Dr. John Boslego, PATH
    • Merck Hepatitis B vaccine technology transfer to China (15 min)
      • Confirmed Speaker: Mr. Sanjeev Jindal, Merck
    • Sanofi Pasteur Influenza vaccine technology transfer to Brazil (15 min)
      • Confirmed Speaker: Dr. Rene Labatut, Sanofi Pasteur
    • Meningococcal A vaccine technology transfer to India (20 min)
      • Confirmed Speaker: Dr. Suresh Jadhav, Serum Institute of India
      • Confirmed Speaker: Dr. Jean-Marie Preaud, PATH
    • Netherlands Vaccine Institute support for developing country manufacturers (15 min)
      • Confirmed Speaker: Dr. Claire Boog, NVI
    • Case studies panel discussion (15 min)

 

LUNCH – 12:30pm-2:00pm

 

September 18, 2010 – Afternoon Session – 2:00pm-6:00pm
Drivers and Decision Points

  1. Factors to consider in determining what technologies are best-suited for individual nations’ short, mid and long-term goals – 2:00pm-3:00pm
    Invited Moderator: Dr. N.K. Ganguly, Former Director-General, Indian Council of Medical Research
    • Infrastructure limitations and solutions (15 min)
      • Confirmed Speaker: Mr. Patrick Tippoo, Biovac, South Africa
    • Regulatory environment (15 min)
      • Confirmed Speaker: Dr. Julie Milstien, University of Maryland School of Medicine
    • Access to Technology (15 min)
      • Confirmed Speaker: Dr. Mark Rohrbaugh, US National Institutes of Health
    • Panel discussion (15 min)
  2. Matching public health needs and market opportunities: factors influencing vaccine capacity-building – 3:00pm-4:00pm
    Confirmed Moderator: Dr. Altaf Lal, MSD Wellcome Trust Hilleman Laboratories
    • Public market response to public health needs (20 min)
      • Confirmed Speaker: Mr. Gerard Cunningham, Gates Foundation
    • Emerging private markets (20 min)
      • Confirmed Speaker: Dr. Altaf Lal, MSD Wellcome Trust Hilleman Laboratories
    • Roundtable discussion (20 min)

 

COFFEE BREAK – 4:00pm-4:30pm

 

  1. The path forward: Increasing vaccine production capacity in developing countries – 4:30pm-5:30pm
    IVTW Staff Coordinator: Christina Hartman (Christina.Hartman@hhs.gov)
    Confirmed Moderator: Dr. Gerald Parker, Principal Deputy Assistant Secretary for Preparedness and Response, US Department of Health and Human Services
    • An integrated approach: translating policy development into program implementation (15 min)
      • Confirmed Speaker: Dr. Maria Julia Marinissen, US Department of Health and Human Services
    • Partnership models (15 min)
      • Confirmed Speaker: Dr. Marie-Paule Kieny, World Health Organization
    • Research needed for new technologies (15 min)
      • Confirmed Speaker: Dr. Jonathan Seals, US Department of Health and Human Services
    • Technical support to implement new vaccine technologies (15 min)
      • Confirmed Speaker: Dr. John Boslego, PATH
    • Panel Discussion (15 min)
  2. Closing Remarks by Dr. Nils Daulaire, Director of the Office of Global Health Affairs, US Department of Health and Human Services – 5:30-5:45pm
  3. Co-Chairs’ Commencement – 5:45pm-6:00pm

 

Conference Adjourns